Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)

Timothy W. Synold, Melissa Plets, Catherine M. Tangen, Elisabeth I. Heath, Ganesh S. Palapattu, Philip C. Mack, Mark N. Stein, Maxwell V. Meng, Primo Lara, Nicholas J. Vogelzang, Ian Murchie Thompson, Christopher W. Ryan

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)'. Together they form a unique fingerprint.

    Medicine & Life Sciences